Skip to main content
. 2022 Nov 24;24(2):315–324. doi: 10.1007/s40257-022-00741-9
Roflumilast cream 0.3% is a potent inhibitor of phosphodiesterase 4 (PDE4).
Topical application results in higher concentrations in the skin than plasma, suggesting local PDE4 inhibition in the skin.